X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (140) 140
index medicus (103) 103
hiv infections - virology (78) 78
virology (77) 77
infectious diseases (74) 74
hiv infections - drug therapy (71) 71
immunology (64) 64
microbiology (57) 57
hiv-1 - genetics (56) 56
hiv (55) 55
hiv-1 - drug effects (47) 47
hiv-1 - physiology (47) 47
hiv infections - immunology (46) 46
male (46) 46
adult (43) 43
infection (41) 41
viral load (41) 41
immunodeficiency-virus type-1 (38) 38
hiv-1 (37) 37
human immunodeficiency virus--hiv (37) 37
female (36) 36
hiv infection (36) 36
research (35) 35
antiretroviral therapy (31) 31
health aspects (31) 31
viruses (30) 30
aids (29) 29
anti-hiv agents - therapeutic use (28) 28
human-immunodeficiency-virus (27) 27
middle aged (26) 26
hiv-1 - immunology (25) 25
human immunodeficiency virus (24) 24
mutation (24) 24
anti-hiv agents - pharmacology (23) 23
biochemistry (22) 22
culture media (22) 22
enzymology (22) 22
antiretroviral therapy, highly active (21) 21
antiviral agents (21) 21
beer (21) 21
cd4 lymphocyte count (21) 21
chemistry (21) 21
compositions thereof (21) 21
human necessities (21) 21
hygiene (21) 21
medical or veterinary science (21) 21
metallurgy (21) 21
microorganisms or enzymes (21) 21
mutation or genetic engineering (21) 21
preparations for medical, dental, or toilet purposes (21) 21
propagating, preserving or maintaining microorganisms (21) 21
replication (21) 21
spirits (21) 21
vinegar (21) 21
wine (21) 21
infections (20) 20
lymphocytes (20) 20
acquired immune deficiency syndrome--aids (19) 19
dendritic cells (19) 19
drug therapy (19) 19
hiv-1 - isolation & purification (19) 19
pharmacology & pharmacy (19) 19
virus diseases (19) 19
active antiretroviral therapy (18) 18
protease inhibitors (18) 18
cd4 t-cells (17) 17
drug-resistance (17) 17
genotype (17) 17
organic chemistry (17) 17
peptides (17) 17
rna, viral - blood (17) 17
virus replication (17) 17
anti-hiv agents - administration & dosage (16) 16
care and treatment (16) 16
cd4-positive t-lymphocytes - virology (16) 16
genetic aspects (16) 16
in-vivo (16) 16
therapy (16) 16
virus replication - drug effects (16) 16
acquired immune deficiency syndrome (15) 15
aids/hiv (15) 15
disease progression (15) 15
drug resistance (15) 15
general tagging of cross-sectional technologies spanning over several sections of the ipc (15) 15
general tagging of new technological developments (15) 15
highly active antiretroviral therapy (15) 15
investigating or analysing materials by determining theirchemical or physical properties (15) 15
measuring (15) 15
mutations (15) 15
physics (15) 15
research article (15) 15
specific therapeutic activity of chemical compounds ormedicinal preparations (15) 15
t cells (15) 15
t-cells (15) 15
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (15) 15
technologies for adaptation to climate change (15) 15
technologies or applications for mitigation or adaptation againstclimate change (15) 15
testing (15) 15
antiretroviral drugs (14) 14
biology (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (259) 259
French (8) 8
Spanish (6) 6
German (3) 3
Portuguese (2) 2
Chinese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Translational Medicine, ISSN 1479-5876, 12/2011, Volume 9, Issue 1, pp. 208 - 208
Background: The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction of responses with the most potent antiviral activity and... 
Epitope | HIV specific CTL | Vaccine immunogen design | Clade B | Entropy | Functional avidity | HLA | Clade C | Immune correlate | IMMUNE CONTROL | MEDICINE, RESEARCH & EXPERIMENTAL | clade B | LYMPHOCYTE RESPONSES | clade C | FUNCTIONAL-AVIDITY | HLA-B | HUMAN-IMMUNODEFICIENCY-VIRUS | GAG | ESCAPE | entropy | vaccine immunogen design | SELECTION PRESSURE | functional avidity | immune correlate | epitope | HIV-1 INFECTION | TYPE-1 | Amino Acid Sequence | Multivariate Analysis | Conserved Sequence - genetics | Species Specificity | HIV Infections - virology | Humans | Peptides - immunology | Male | Virus Replication - immunology | Histocompatibility Antigens Class I - genetics | Viral Load - immunology | Genetic Heterogeneity | T-Lymphocytes - virology | HIV Infections - immunology | HIV-1 - immunology | HIV-1 - physiology | Alleles | T-Lymphocytes - immunology | gag Gene Products, Human Immunodeficiency Virus - immunology | Peru | Cohort Studies | Prevention | Care and treatment | Immune response | Physiological aspects | Research | T cells | HIV infection | Health aspects | Risk factors | Studies | Medical research | T cell receptors | Immunology | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Estadística biosanitària | 92C Physiological, cellular and medical topics | 92 Biology and other natural sciences | Biology | Classificació AMS | Matemàtiques i estadística | Estadística aplicada | Àrees temàtiques de la UPC | Biologia
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9883, pp. 2109 - 2117
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 2/2011, Volume 203, Issue 4, pp. 473 - 478
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 10/2016, Volume 19, Issue 8(Suppl 7), pp. 21487 - n/a
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e114142
Background: HIV-1 infection increases plasma levels of inflammatory markers. Combination antiretroviral therapy (cART) does not restore inflammatory markers to... 
CONTROLLED-TRIAL | ACTIVATION | CD4 | T-CELL RECOVERY | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | MICROBIAL TRANSLOCATION | SIV INFECTION | RALTEGRAVIR INTENSIFICATION | PROTEASE INHIBITORS | D-DIMER | HIV Infections - blood | Prospective Studies | Humans | Middle Aged | Raltegravir Potassium - administration & dosage | Raltegravir Potassium - therapeutic use | Male | Biomarkers - blood | HIV Integrase Inhibitors - administration & dosage | Inflammation - blood | HIV Infections - immunology | HIV Integrase Inhibitors - therapeutic use | Adult | Female | HIV Infections - drug therapy | Usage | HIV patients | Inflammation | T cells | HIV (Viruses) | Infection | Highly active antiretroviral therapy | Protease inhibitors | Proteases | Analysis | Hepatitis C virus | Health aspects | HIV infection | Antiretroviral drugs | Composition | CD8 antigen | Markers | Lymphocytes T | Proteinase inhibitors | T cell receptors | Infections | Patients | Antiretroviral therapy | CD4 antigen | Amplification | Cell activation | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Integrals | Human immunodeficiency virus--HIV | Replication | Sampling methods | Plasma levels | Dimers | Antiretrovirals | HIV infections | Inflamació | Marcadors bioquímics | Infeccions per VIH | Biochemical markers | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Nature Medicine, ISSN 1078-8956, 04/2010, Volume 16, Issue 4, pp. 460 - 465
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, p. e0175899
Journal Article
Science, ISSN 0036-8075, 8/2007, Volume 317, Issue 5840, pp. 944 - 947
Journal Article